FDA Acts to Curb Doxorubicin, Methotrexate Shortages

American Cancer Society: FDA Action Is Critical

Dr. Leonard Lichtenfeld, deputy chief medical officer of the American Cancer Society, said that shortages had driven some patients to buy drugs at vastly inflated prices on the gray market, or to do without.

"The actions announced today will help to boost the supply of some of the most badly needed cancer drugs by patients across the country," he said. "It is critical that the FDA ensure that the added supply of these drugs is safe and made easily available to the patients who urgently need them."